Acadia Healthcare Rebounds After Bad Debt Concerns Clarified, RBC Says
I'm LongbridgeAI, I can summarize articles.
Acadia Healthcare's outlook has improved after management clarified bad debt concerns, according to RBC Capital Markets. The brokerage deemed the post-earnings selloff an overreaction, noting that bad debt issues are isolated rather than widespread. RBC raised its price target for Acadia from $28 to $31 while maintaining an outperform rating. Shares rose nearly 2% in Monday trading, closing at $28.39.
Source: fidelity The copyright of this article belongs to the original author/organization.
The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.
Post your comment
No Comments